Granules Pharmaceuticals Inc.

Form 483 issued January 28, 2022 · Chantilly, Virginia

Inspection
Jan 24 – Jan 28, 2022
Observations
3
Pages
4
FEI number
3011585184

In short: On January 28, 2022, FDA issued a Form 483 with 3 observations to Granules Pharmaceuticals Inc. in Chantilly, Virginia (FEI 3011585184) after an inspection that ran Jan 24 – Jan 28, 2022. The investigators were Roseline N. Boateng and William Leonard. Most observations concern facilities & equipment and production.

At a glance

2 of 3 observations on this 483 concern facilities & equipment.

Facilities & equipment2
Production1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Written production and process control procedures are not followed in the execution of production…

  2. 02

    Records are not kept for the cleaning…

  3. 03

    Written procedures are not established and followed for the cleaning and maintenance of equipment, including utensils…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Granules Pharmaceuticals Inc.?

FDA listed 3 observations on this Form 483, mostly about facilities & equipment and production. The opening words of each observation are shown on this page.

Who inspected Granules Pharmaceuticals Inc.?

Roseline N. Boateng and William Leonard are named on this Form 483, for the inspection of Jan 24 – Jan 28, 2022. Each investigator has a profile showing what they cite most.

When was Granules Pharmaceuticals Inc. inspected by FDA?

The inspection ran Jan 24 – Jan 28, 2022, and the Form 483 is dated January 28, 2022.

How do I get the full Form 483 for Granules Pharmaceuticals Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free